In the realm of small-cap stocks, a Piotroski F-score of 9 signals robust financial health, making these companies attractive for savvy investors. High scores reflect strong fundamentals, including profitability, low debt, and solid cash flow.
For those seeking growth potential in smaller companies, these high-scoring small-cap stocks may offer promising opportunities for long-term gains.
1. Sun Pharma Industries
Sun Pharma, India’s largest pharmaceutical company, specialises in generic and speciality medicines with a strong presence in over 100 countries. Founded in 1983, the company focuses on therapeutic areas like cardiology, psychiatry, neurology, and oncology. Its diverse product portfolio and global reach drive continued growth and innovation.
Sun Pharma Industries Limited has a majority stake held by the promoters at 54.48 percent, domestic institutional investors at 18.48 percent, and the public at 8.89 percent as of September 2024.
Sun Pharma Industries Limited’s revenue from operations has increased by 10.50 percent from Rs. 43,886 crore in FY23 to Rs. 48,497 crore in FY24. The company’s net profit has increased from Rs. 8,513 crore in FY23 to Rs. 9,610 crore in FY24, which has grown by 12.88 percent.
With a market capitalisation of Rs. 4,33,067 crores, Sun Pharma Industries Limited’s share price closed at Rs. 1,804.95 per equity share.
2. Hindustan Aeronautics Ltd. (HAL)
Hindustan Aeronautics, a premier aerospace and defence company, supplies aircraft, helicopters, and related systems to the Indian Armed Forces. Established in 1940, HAL plays a critical role in India’s defence sector with manufacturing, research, and service capabilities, supporting indigenous development in aviation and advanced defence technologies.
Hindustan Aeronautics Limited has a majority stake held by the promoters at 71.64 percent, domestic institutional investors at 8.37 percent, and the public at 8.13 percent as of September 2024.
Hindustan Aeronautics Limited’s revenue from operations has increased by 12.82 percent from Rs. 26,928 crore in FY23 to Rs. 30,381 crore in FY24. The company’s net profit has increased from Rs. 7,595 crore in FY23 to Rs. 5,811 crore in FY24, which has grown by 30.7 percent.
With a market capitalisation of Rs. 2,92,923 crores, Hindustan Aeronautics Limited’s share price closed at Rs. 4,380 per equity share.
3. Alkem Laboratories
Founded in 1973, Alkem Laboratories is a top pharmaceutical manufacturer in India known for producing branded generics, active pharmaceutical ingredients (APIs), and nutraceuticals. Operating across 50+ countries, Alkem has a strong focus on anti-infective, gastrointestinal, and pain management medications, making it a trusted healthcare provider globally.
Alkem Laboratories Limited has a majority stake held by the promoters at 55.66 percent, domestic institutional investors at 19.21 percent, and the public at 16.12 percent as of September 2024.
Alkem Laboratories Limited’s revenue from operations has increased by 9.21 percent from Rs. 11,599 crore in FY23 to Rs. 12,668 crore in FY24. The company’s net profit has increased from Rs. 1,007 crore in FY23 to Rs. 1,811 crore in FY24, which has grown by 79.8 percent.
With a market capitalisation of Rs. 68,092 crores, Alkem Laboratories Limited’s share price closed at Rs. 5,695 per equity share.
Also read…
4. Gillette India
Gillette India, part of Procter & Gamble, specialises in grooming products for men, including razors, blades, and shaving accessories. With a legacy of quality and innovation, the company’s well-known brands like Gillette and Venus hold a dominant position in the Indian grooming market, catering to millions of consumers.
Gillette India Limited has a majority stake held by the promoters at 75.00 percent, domestic institutional investors at 10.79 percent, and the public at 10.96 percent as of September 2024.
Gillette India Limited’s revenue from operations has increased by 6.2 percent from Rs. 2,477 crore in FY23 to Rs. 2,633 crore in FY24. The company’s net profit has increased from Rs. 356 crore in FY23 to Rs. 412 crore in FY24, which has grown by 15.7 percent.
With a market capitalisation of Rs. 32,050 crores, Gillette India Limited’s share price closed at Rs. 9,836 per equity share.
5. Piramal Pharma
Piramal Pharma is a leading player in the pharmaceutical and healthcare solutions industry, with a strong focus on speciality pharmaceuticals, consumer products, and contract development and manufacturing (CDMO) services. The company operates globally, leveraging innovation and a commitment to quality to deliver high-impact health solutions across diverse therapeutic areas.
Piramal Pharma Limited has a majority stake held by the promoters and FIIs with 34.94 percent and 31.73 percent, respectively. Domestic institutional investors at 13.80 percent, and the public at 19.06 percent as of September 2024.
Piramal Pharma Limited’s revenue from operations has increased by 15.40 percent from Rs. 7,082 crore in FY23 to Rs. 8,171 crore in FY24. The company’s net profit has gone from negative Rs. 186 crore in FY23 to positive Rs. 18 crore in FY24.
With a market capitalisation of Rs. 37,120 crores, Piramal Pharma Limited’s share price closed at Rs. 280 per equity share.
Written By Fazal Ul Vahab C H
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
Start Your Stock Market Journey Today!
Want to learn Stock Market trading and Investing? Make sure to check out exclusive Stock Market courses by FinGrad, the learning initiative by Trade Brains. You can enroll in FREE courses and webinars available on FinGrad today and get ahead in your trading career. Join now!!
